Clinical Trials | April 22, 2026
Asahi Kasei pushes into human trials with new autoimmune drug candidate
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
AI-enabled learning platform to enhance clinical quality, patient outcomes, and staff engagement across Eastern India network
The launch coincides with IBS Awareness Month in April
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Subscribe To Our Newsletter & Stay Updated
